MYMLEP

Class [5]
Pharmaceutical Products

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of lipoatrophy, lipodystrophy, hypothalamic amenorrhea, leptin deficiency, diabetes mellitus, hepatomegaly, hypertriglyceridemia, hypercholesterolemia, fatty liver disease including non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, metabolic disorders, endocrine conditions and disorders, hormonal diseases and disorders, cardiovascular diseases and disorders, reproductive disorders; pharmaceutical preparations; none of all above-mentioned preparations and products containing mint or being mint flavoured, or containing or being flavoured with mint derivatives.